BlueCrest Capital Management’s ARYA Sciences Acquisition Corp V Class A Ordinary Shares ARYE Stock Holding History

BlueCrest Capital Management’s Portfolio ARYE Stock Details ARYE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-250,000	Closed	-$2.52M	–	299
2022 Q4	$2.52M	Hold	250,000	–	–	0.07%	87
2022 Q3	$2.45M	Hold	250,000	–	–	0.07%	107
2022 Q2	$2.43M	Hold	250,000	–	–	0.09%	103
2022 Q1	$2.43M	Hold	250,000	–	–	0.08%	143
2021 Q4	$2.42M	Hold	250,000	–	–	0.08%	182
2021 Q3	$2.47M	Buy	+250,000	New	+$2.48M	0.07%	192

Other funds holding ARYE

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

CIM

Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return

BlueCrest Capital Management's ARYE Position: Q1 2023 in Review

BlueCrest Capital Management sold out of ARYA Sciences Acquisition Corp V Class A Ordinary Shares (ARYE) in Q1 2023, closing a stake of 250,000 shares — an estimated $2.52M sold.

BlueCrest Capital Management first reported a position in ARYE in Q3 2021 and held it in 6 quarters. The position peaked at $2.52M in Q4 2022. 48 funds tracked by Wall St. Rank hold ARYE as of Q1 2023.

BlueCrest Capital Management reported no remaining ARYA Sciences Acquisition Corp V Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
BlueCrest Capital Management sold 250,000 ARYA Sciences Acquisition Corp V Class A Ordinary Shares shares in Q1 2023, an estimated $2.52M.
BlueCrest Capital Management first reported a position in ARYA Sciences Acquisition Corp V Class A Ordinary Shares in Q3 2021 and held it in 6 quarters.
BlueCrest Capital Management's ARYA Sciences Acquisition Corp V Class A Ordinary Shares position peaked at $2.52M in Q4 2022.
48 funds tracked by Wall St. Rank held ARYA Sciences Acquisition Corp V Class A Ordinary Shares as of Q1 2023.

Based on BlueCrest Capital Management's 13F filing for Q1 2023, filed 15 May 2023.